Methods of treating pulmonary fibrosis
US7754207B2 · kind B2 · utility
0Cited by
10References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 26, 2007 |
| Grant date | Jul 13, 2010 |
| Priority date | — |
| Expiry date | Mar 8, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/00
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Methods for treating pathological pulmonary conditions and bleomycin associated pulmonary fibrosis administer IL-16 antagonists, for example, anti-IL-16 antibodies, to subjects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.